SIQ17, an EGFR inhibitor, blocks the ATP-binding site with an IC50 of 0.62 nM, demonstrating more effective EGFR-TK inhibitory activity than the known inhibitor Erlotinib (IC50 of 20 nM). SIQ17 is applicable in cancer research [1].
Molecular Weight:
489.63
CAS Number:
[2151881-74-0]
Formula:
C32H27NO2S
Target:
EGFR
T87395
* VAT and and shipping costs not included. Errors and price changes excepted
